Global Custom Market Research Reports Provider Company

phone

The Lubrizol Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 06 Jul 2018
  • Number of Pages: 29
  • Category: Company Profile
  • Country: United States of America
Summary

The Lubrizol Corporation (Lubrizol), a subsidiary of Berkshire Hathaway Inc., is a specialty chemical company that produces and supplies technologies to the global transportation, industrial, and consumer markets. Its products and services include engine additives, driveline additives, industrial specialties products, engineered polymers, coatings, and life science solutions. Lubrizols products find application in engine oils, transmission fluids, gear oils, metalworking fluids, compressor lubricants, specialty driveline lubricants, fuel additives, pipelines, greases for transportation and industrial applications, over-the-counter pharmaceutical products, performance coatings, personal care products, sporting goods and plumbing and fire sprinkler systems. The company operates through a network of manufacturing facilities, laboratories, sales offices and technical offices in countries across North America, Europe and Asia-Pacific. Lubrizol is headquartered in Wickliffe, Ohio, the US.

The Lubrizol Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData


List of Tables 4
List of Figures 4
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Lubrizol Corporation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
The Lubrizol Corporation, Medical Devices Deals, 2012 to YTD 2018 9
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Particle Sciences Enters Into Licensing Agreement With Lyotropic Therapeutics For Drug Delivery Technology 11
IDP Discovery Pharma Enters into Collaboration Agreement with BCN Peptides 12
Particle Sciences Enters Into Co-Development Agreement With Actavis 13
Particle Sciences Enters Into Co-Development Agreement With Pernix Therapeutics 14
Licensing Agreements 15
Glenmark Pharma Enters into Licensing Agreement with Particle Sciences 15
Acquisition 16
Lubrizol Acquires Particle Sciences 16
Lubrizol Completes Acquisition Of Lipotec, Supplier Of Over The Counter Products 17
The Lubrizol Corporation - Key Competitors 19
The Lubrizol Corporation - Key Employees 20
The Lubrizol Corporation - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Strategy And Business Planning 23
Aug 22, 2017: Lubrizol LifeSciences Announces Vesta Expansion 23
Jan 19, 2017: Lubrizol Skin Care Actives Combine Under One Name in North America 24
Corporate Communications 25
Jan 03, 2017: Eric R. Schnur Succeeds James L. Hambrick as Lubrizol Chairman and CEO 25
Other Significant Developments 26
Jun 06, 2017: Lubrizol Invests $60 Million to Expand Particle Sciences, Vesta and Other Facilities in 2017 26
Apr 04, 2017: Lubrizol Skin and Dermal Care Integrate to Form Lubrizol Skin Essentials 27
Feb 07, 2017: Lubrizol LifeSciences Announces New Compounding Capabilities 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List Of Tables

List of Tables
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Key Facts, 2017 2
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Lubrizol Corporation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Lubrizol Corporation, Deals By Therapy Area, 2012 to YTD 2018 8
The Lubrizol Corporation, Medical Devices Deals, 2012 to YTD 2018 9
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Particle Sciences Enters Into Licensing Agreement With Lyotropic Therapeutics For Drug Delivery Technology 11
IDP Discovery Pharma Enters into Collaboration Agreement with BCN Peptides 12
Particle Sciences Enters Into Co-Development Agreement With Actavis 13
Particle Sciences Enters Into Co-Development Agreement With Pernix Therapeutics 14
Glenmark Pharma Enters into Licensing Agreement with Particle Sciences 15
Lubrizol Acquires Particle Sciences 16
Lubrizol Completes Acquisition Of Lipotec, Supplier Of Over The Counter Products 17
The Lubrizol Corporation, Key Competitors 19
The Lubrizol Corporation, Key Employees 20
The Lubrizol Corporation, Other Locations 21
The Lubrizol Corporation, Subsidiaries 21

List Of Figures

List of Figures
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
The Lubrizol Corporation, Medical Devices Deals, 2012 to YTD 2018 9

ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate

View Report

US Physical Therapy Inc (USPh) operates outpatient physical and occupational therapy clinics that offer pre-and post-operative care. The company provides treatment for orthopedic-related disorders, preventative care, sports-related injuries, rehabilitation of

View Report

University of Copenhagen (UCPH) is a university and research institution that offers educational and research programs and services. The university services include graduate and undergraduate courses, research programs, masters programs,

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports